[1]
Almeida, L.F.C. de et al. 2026. Progression-free survival as a surrogate endpoint for overall survival in antibody-drug conjugate trials for advanced breast cancer: a systematic review and meta-analysis. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1028.